Azole-echinocandin combination therapy for invasive aspergillosis. A randomized pragmatic superiority trial (IA-DUET)
Latest Information Update: 04 Jul 2024
At a glance
- Drugs Anidulafungin (Primary) ; Isavuconazole (Primary) ; Isavuconazole (Primary) ; Posaconazole (Primary) ; Posaconazole (Primary) ; Voriconazole (Primary) ; Voriconazole (Primary)
- Indications Aspergillosis
- Focus Therapeutic Use
- Acronyms IA-DUET
- 04 Jul 2024 This study has been Completed in Belgium, According to European Clinical Trials Database record.
- 06 May 2024 Status changed from recruiting to discontinued due to futility.
- 29 Oct 2020 New trial record